期刊文献+

p110δ突变失活上调血管MMPs表达并引发血管壁结构损伤 被引量:2

Improved MMPs in p110δ-mutant mice contributes to rupture of thoracic aorta
下载PDF
导出
摘要 目的:研究p110δD910A基因突变失活(p110δ-mutant)对动脉血管结构的影响及机制。方法:选取8周龄雄性的野生型(WT)小鼠与p110δ-mutant小鼠(n=20;20-25 g),取胸主动脉进行石蜡包埋,HE染色,采用免疫组化、免疫荧光以及real-time PCR等方法,研究p110δ突变对小鼠动脉血管形态变化的影响及机制。结果:与WT相比,p110δ突变失活后小鼠主动脉血管壁变薄,管腔变大。p110δ突变失活后主动脉血管壁形态紊乱,弹力纤维局部断裂,血管中内皮细胞凋亡。p110δ突变失活后主动脉血管α平滑肌肌动蛋白(α-SMA)表达量、胶原Ⅰ和胶原Ⅳ含量减少。p110δ突变失活后主动脉血管中的基质金属蛋白酶-3(MMP-3)和MMP-9的mRNA水平明显升高。结论:PI3K活性在维持小鼠动脉血管的正常形态中起重要作用,p110δ突变失活后可能通过上调基质金属蛋白酶的表达促进血管壁结构的破坏。 AIM: To observe the pathological characteristics of the thoracic aorta in the p110δ-mutant mice.METHODS: The thoracic aorta of wild type male mice and p110δ-deficient male mice( 8 weeks old) were achieved. HE,IHC and IF staining were performed on the paraffin fixed arterial sections. The mRNA expression was detected by real-time PCR. RESULTS: The vascular wall became thinner and the vessel diameter enlarged after inactivating mutation of p110δ.After inactivating mutation of p110δ,the smooth muscle cells showed vacuolar degeneration,morphological disorders and elastic fiber local fracture. The collagen content was reduced after inactivating mutation of p110δ. The expression of matrix metalloproteinase-3( MMP-3) and MMP-9 was up-regulated after inactivating mutation of p110δ. CONCLUSION: Inactivating mutation of p110δ may contribute to the injury of artery vascular wall by up-regulation of MMPs.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2014年第11期1987-1992,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.31271455 No.31200861) 国家科技部“973”项目(No.2010CB529703)
关键词 p110δ 基质金属蛋白酶 动脉血管壁损伤 p110δ Matrix metalloproteinase Artery vascular wall injury
  • 相关文献

参考文献18

  • 1Fougerat A,Gayral S,Malet N,et al.Phosphoinositide 3-kinases and their role in inflammation:potential clinical targets in atherosclerosis?[J].Clin Sci (Lond),2009,116(11):791-804.
  • 2Harris SJ,Foster JG,Ward SG.PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies[J].Curr Opin Invest Drugs,2009,10(11):1151-1162.
  • 3Wymann MP,Solinas G.Inhibition of phosphoinositide 3-kinase γattenuates inflammation,obesity,and cardiovascular risk factors[J].Ann N Y Acad Sci,2013,1280:44-47.
  • 4Geng L,Tan J,Himmelfarb E,et al.A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase,IC486068,enhances radiation-induced tumor vascular destruction[J].Cancer Res,2004,64(14):4893-4899.
  • 5Swift MR,Weinstein BM.Arterial-venous specification during development[J].Circ Res,2009,104 (5):576-588.
  • 6Krecki R,Kasprzak JD.Advanced peripheral arterial disease in a 59-year-old man with suspected acute coronary syndrome and normal coronary angiogram[J].Postepy Kardiol Interwencyjnej,2013,9 (3):307-309.
  • 7Deane JA,Fruman DA.Phosphoinositide 3-kinase:diverse roles in immune cell activation[J].Annu Rev Immunol,2004,22:563-598.
  • 8Kobayashi T,Hayashi Y,Taguchi K,et al.ANG II enhances contractile responses via PI3-kinase p110 delta pathway in aortas from diabetic rats with systemic hyperinsulinemia[J].Am J Physiol Heart Circ Physiol,2006,291 (2):H846-H853.
  • 9Van Lint P,Libert C.Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation[J].J Leukoc Biol,2007,82(6):1375-1381.
  • 10Hire JM,Evanson JL,Johnson PC,et al.Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated,concentrated platelets from healthy male donors[J].J Orthop Surg Res,2014,9:29.

同被引文献13

  • 1朱运奎,金远林,肖永久,汤育瑛,汪莉,李继东.弹力蛋白酶和基质金属蛋白酶在肺组织破坏中协同作用的实验研究[J].中国病理生理杂志,2005,21(4):784-787. 被引量:7
  • 2Hu J, Xia X, Cheng A, et al. A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory sub- unit: a novel cancer therapy[ J]. Mol Cancer Ther, 2008, 7(12) :3719-3728.
  • 3Wang G, Cao X, Lai S, et al. PI3K stimulates DNA syn- thesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCTA [ J]. Mol Cancer Ther, 2013, 12(10) :2100-2109.
  • 4Wu DM, Zhang P, Liu RY, et al. Phosphorylation and changes in the distribution of nucleolin promote tumor me- tastasis via the PI3K/Akt pathway in colorectal carcinoma [J]. FEBS Lett, 2014, 588(10):1921-1929.
  • 5Deng Y, Wang J, Wang G, et al. p55PIK transcriptional- ly activated by MZF1 promotes eolorectal cancer cell pro- liferation[J]. Biomed Res Int, 2013, 2013:868131.
  • 6Zhou J, Chen GB, Tang YC, et al. Genetic and bioinfor- matic analyses of the expression and function of PI3 K regu- latory subunit PIER3 in an Asian patient gastric cancer library[J]. BMC Med Genomics, 2012, 5:34.
  • 7Wang G, Chen C, Yang R, et al. p55PIK-PI3K stimu- lates angiogenesis in colorectal cancer cell by activating NF-κB pathway [ J ]. Angiogenesis, 2013,16 ( 3 ) : 561- 573.
  • 8Wang G, Deng Y, Cao X, et al. Blocking p55PIK signa- ling inhibits proliferation and induces differentiation of leu- kemia cells[J]. Cell Death Differ, 2012,19( 11 ) : 1870- 1879.
  • 9Lv F, Yu Y, Wang G, et al. Mechanisms by which the N- terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cy- tokine release in human keratinocytes [ J ]. Mol Med Rep, 2015,11 (5) : 3753-3759.
  • 10Brown KK, Toker A. The phosphoinositide 3-kinase path- way and therapy resistance in cancer [ J ]. F100OPrime Rep, 2015, 7 : 13.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部